Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Caspofungin × Gastrointestinal × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Blood Specimen Collection 78 Surveys and Questionnaires 71 Surgical Procedures, Operative 40 Drug Therapy 38 Observation 34 Colonoscopy 33 Bevacizumab 33 Biopsy 28 Hepatectomy 27 Immune Checkpoint Inhibitors 25 Neoadjuvant Therapy 23 Radiotherapy 22 Capecitabine 22 regorafenib 20 Oxaliplatin 20 Magnetic Resonance Spectroscopy 18 Interviews as Topic 18 Endoscopic Mucosal Resection 18 lenvatinib 17 Liquid Biopsy 17 Specimen Handling 16 Immunohistochemistry 16 Gastroscopy 16 Gastrectomy 16 Sorafenib 15 Pancreaticoduodenectomy 14 Esophagectomy 13 Endoscopic Ultrasound-Guided Fine Needle Aspiration 13 Tomography, X-Ray Computed 12 Fluorouracil 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01686607 2024-10-21

MYCOS

Astellas Pharma Inc

40,110 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡